Onconova Therapeutics (ONTX) Reports Q2 Loss of $0.41/Share
Tweet
Share
E-mailGet Alerts ONTX Hot Sheet
Join SI Premium – FREE
Onconova Therapeutics (NASDAQ: ONTX) reported Q2 EPS of ($0.41), versus ($0.77) reported last year. Revenue for the quarter came in at $123 thousand, versus $125 thousand reported last year.
For earnings history and earnings-related data on Onconova Therapeutics (ONTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stitch Fix (SFIX) Tops Q4 EPS by 4c; Offers Guidance
- Cintas beats estimates but stock edges lower
- NeoVolta Inc. (NEOV) Misses Q3 EPS by 17c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
